Pardeep Brar, MD
Gastroenterology · French Camp
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 31 years
- Graduated 1995
Offices
2 locations · County of San Joaquin · Permanente Medical Group Inc
Hospitals listed: Doctors Medical Center · Memorial Medical Center · San Joaquin General Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brar’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C54142 · Current
Licensed to practise in California · since 2010 · expires 2027-09-30 · Punjab University, Dayanand Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Doctors Medical CenterModesto, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.02 to 1.71), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.35 (0.81 to 1.9) · 6,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.281, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.326, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.183, Oct 2024 – Sep 2025
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- San Joaquin General HospitalFrench Camp, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Joaquin County ClinicsPatients rate it 2 of 5 · 62% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.49 (1.07 to 1.91), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.72 (0.79 to 2.64) · 1,588 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.162, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.097, Oct 2024 – Sep 2025
See every measure and the patient survey for Doctors Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 3 the same, 1 worse of 6 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.02 to 1.71) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.35 (0.81 to 1.9) · 6,296 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.281 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.326 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.183 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.31 to 2.23) · 1,396 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 183.31 (147.26 to 219.36) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 4.1 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.2 · 276 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.8 · 321 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 364 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 767 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 3,719 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,050 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,169 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.12 (2.19 to 6.06) · 1,622 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.23 to 4.04) · 1,601 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 14.79 (5.73 to 23.85) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (0.75 to 9.23) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.9 · 67 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.484 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.582 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 424 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24 · 682 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 36.6 · 326 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 70.5 · 378 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 366 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 564 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.7 · 120 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.4) · 573 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.7) · 303 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,045 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 36% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for San Joaquin General Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 3 better, 2 the same, 1 worse of 6 measures. Readmissions: 0 better, 5 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.49 (1.07 to 1.91) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.72 (0.79 to 2.64) · 1,588 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.162 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.097 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.54 (0.48 to 2.59) · 292 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 174.57 (117.75 to 231.38) · 40 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.2 · 53 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 639 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 1,812 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.24 (0.87 to 5.62) · 443 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.36 to 4.64) · 467 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.63 (3.98 to 23.29) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.71 (2.49 to 10.92) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 77 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 1.808 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.328 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 117 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -20.4 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 45.4 · 104 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 119 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.5) · 128 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 41 cases | No different | Jan 2024 – Dec 2024 |
What patients said (801 patients answered, 28% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 36% |
| "YES", patients would definitely recommend the hospital | 62% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$89,881
Medicare paid this office $89,881 for 397 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 107 | $10,101 | $92 |
| Short return visit (20+ min) | 93 | $7,320 | $60 |
| New patient visit (30+ min) | 106 | $7,310 | $69 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 116 | $6,615 | $56 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 41 | $6,427 | $149 |
See all 17 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 107 | $10,101 | $92 |
| Short return visit (20+ min) | 93 | $7,320 | $60 |
| New patient visit (30+ min) | 106 | $7,310 | $69 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 116 | $6,615 | $56 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 41 | $6,427 | $149 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 34 | $5,430 | $160 |
| Return visit (30+ min) | 51 | $5,297 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $4,528 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $4,139 | $84 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 12 | $3,883 | $324 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $3,046 | $145 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $1,797 | $72 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 16 | $1,648 | $87 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $1,556 | $120 |
| Colorectal cancer screening; flexible sigmoidoscopy | 27 | $1,169 | $43 |
| Incision of pancreatic outlet using a flexible endoscope | 18 | $658 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 54 | $450 | $8 |
Procedures Medicare counted
| Colonoscopy | 80 | More than 74% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 77 | More than 71% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | 69 | 73 | 80 | 92 | 118 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 64 | 38 | 39 | 29 | 37 | 43 |
| Biopsy of large bowel using a flexible endoscope | 65 | 46 | 23 | – | 28 | – |
| Diagnostic exam of large bowel using a flexible endoscope | 31 | 25 | 22 | 13 | 19 | 13 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | 12 | 18 | – | 15 | 25 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 14 | 17 | – | 12 | 19 | 19 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
397 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 12% · Women 59% · Also on Medicaid 46% · Health risk score 1.88. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 45% · Coronary heart disease 36% · Chronic kidney disease 36% · Depression 29% · Heart failure 27% · Atrial fibrillation 26% · COPD 24% · Cancer 16% · Stroke 14% · Dementia 13%.
The office billed $504,780, Medicare allowed $118,429 and paid $89,881; for 1,033 services of 56 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 397 | 1,033 | 73 | 1.88 | $504,780 | $89,881 |
| 2023 | 333 | 862 | 72 | 1.89 | $382,071 | $88,114 |
| 2022 | 335 | 869 | 71 | 1.82 | $364,780 | $82,002 |
| 2021 | 331 | 828 | 73 | 1.80 | $369,668 | $90,290 |
| 2020 | 289 | 891 | 70 | 1.94 | $363,610 | $83,823 |
| 2019 | 403 | 1,118 | 72 | 2.12 | $467,310 | $111,427 |
| 2018 | 371 | 1,132 | 71 | 1.80 | $449,071 | $102,434 |
| 2017 | 415 | 1,412 | 70 | 2.06 | $544,585 | $118,425 |
| 2016 | 391 | 1,032 | 71 | 1.88 | $467,304 | $107,264 |
| 2015 | 363 | 940 | 72 | 1.87 | $505,956 | $100,527 |
| 2014 | 307 | 966 | 70 | 1.95 | $470,300 | $103,968 |
| 2013 | 384 | 1,328 | 70 | 1.79 | $657,212 | $141,728 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $11,060 | $140 |
| Short return visit (20+ min) | 84 | $7,836 | $66 |
| Return visit (30+ min) | 53 | $7,834 | $98 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $6,774 | $183 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 88 | $6,528 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $5,955 | $96 |
| New patient visit (30+ min) | 69 | $5,772 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $4,819 | $105 |
| Biopsy of large bowel using a flexible endoscope | 28 | $3,132 | $112 |
| New patient visit (45+ min) | 25 | $2,951 | $118 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $2,786 | $147 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,569 | $184 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 16 | $1,647 | $87 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,271 | $85 |
| Colorectal cancer screening; flexible sigmoidoscopy | 18 | $931 | $52 |
| Incision of pancreatic outlet using a flexible endoscope | 13 | $385 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $177 | $9 |
2022: 14 services
| Short return visit (20+ min) | 107 | $10,308 | $70 |
| New patient visit (30+ min) | 105 | $7,946 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,860 | $160 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $6,327 | $109 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $5,618 | $194 |
| Return visit (30+ min) | 48 | $5,609 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | $5,297 | $66 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 25 | $4,700 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $3,644 | $83 |
| Colorectal cancer screening; flexible sigmoidoscopy | 37 | $2,121 | $57 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $1,952 | $150 |
| New patient visit (45+ min) | 13 | $1,790 | $138 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 12 | $1,714 | $143 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 63 | $607 | $9 |
2021: 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $11,928 | $166 |
| New patient visit (30+ min) | 120 | $11,018 | $92 |
| Short return visit (20+ min) | 98 | $10,495 | $73 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 39 | $7,745 | $199 |
| Return visit (30+ min) | 49 | $6,505 | $103 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 72 | $5,313 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $4,872 | $85 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,247 | $148 |
| Biopsy of large bowel using a flexible endoscope | 23 | $3,080 | $134 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,124 | $193 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,909 | $112 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,689 | $94 |
| Incision of pancreatic outlet using a flexible endoscope | 11 | $645 | $50 |
| Short return visit | 13 | $526 | $38 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $155 | $10 |
2020: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $14,500 | $86 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 38 | $7,560 | $199 |
| Short return visit (20+ min) | 79 | $6,262 | $57 |
| New patient visit (30+ min) | 80 | $5,761 | $72 |
| Return visit (30+ min) | 60 | $5,401 | $76 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $4,584 | $66 |
| Biopsy of large bowel using a flexible endoscope | 46 | $3,973 | $86 |
| Diagnostic exam of large bowel using a flexible endoscope | 25 | $3,601 | $144 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $2,955 | $197 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 15 | $2,608 | $153 |
| Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,099 | $175 |
| Exam of common bile and/or pancreatic duct using a flexible endoscope | 16 | $1,927 | $101 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,119 | $93 |
| Short return visit | 13 | $465 | $36 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 69 | $332 | $4 |
2019: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $12,726 | $199 |
| New patient visit (30+ min) | 144 | $11,620 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $11,169 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $10,780 | $163 |
| Short return visit (20+ min) | 91 | $7,372 | $59 |
| Return visit (30+ min) | 72 | $7,351 | $84 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 77 | $6,965 | $84 |
| Biopsy of large bowel using a flexible endoscope | 65 | $6,499 | $100 |
| Diagnostic exam of large bowel using a flexible endoscope | 31 | $4,669 | $151 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 13 | $3,424 | $245 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,387 | $88 |
| Incision of pancreatic outlet using a flexible endoscope | 19 | $2,180 | $109 |
| New patient visit (45+ min) | 11 | $1,317 | $120 |
| Exam of common bile and/or pancreatic duct using a flexible endoscope | 11 | $1,282 | $99 |
| Short return visit | 24 | $858 | $36 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 66 | $312 | $5 |
2018: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 102 | $14,239 | $87 |
| New patient visit (30+ min) | 133 | $10,452 | $79 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 49 | $10,271 | $210 |
| Biopsy of large bowel using a flexible endoscope | 82 | $9,301 | $113 |
| Short return visit (20+ min) | 98 | $7,350 | $57 |
| Return visit (30+ min) | 68 | $6,832 | $85 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $5,443 | $74 |
| New patient visit (45+ min) | 33 | $4,025 | $122 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 13 | $3,376 | $260 |
| Exam of common bile and/or pancreatic duct using a flexible endoscope | 23 | $2,726 | $105 |
| Diagnostic exam of large bowel using a flexible endoscope | 17 | $2,512 | $148 |
| Incision of pancreatic outlet using a flexible endoscope | 14 | $1,281 | $91 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,143 | $104 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 131 | $653 | $5 |
| Follow-up observation care per day, typically 15 minutes | 11 | $550 | $34 |
| Short return visit | 15 | $542 | $36 |
2017: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $16,025 | $81 |
| New patient visit (45+ min) | 120 | $12,917 | $108 |
| Short return visit (20+ min) | 140 | $10,138 | $55 |
| Biopsy of large bowel using a flexible endoscope | 86 | $9,377 | $107 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 45 | $8,862 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $8,406 | $136 |
| Return visit (30+ min) | 78 | $7,054 | $78 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $5,978 | $66 |
| Diagnostic exam of large bowel using a flexible endoscope | 33 | $4,825 | $146 |
| New patient visit (30+ min) | 45 | $3,571 | $79 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 13 | $2,831 | $218 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,389 | $88 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,027 | $184 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 15 | $1,581 | $105 |
| Exam of common bile and/or pancreatic duct using a flexible endoscope | 12 | $1,339 | $96 |
| Short return visit | 40 | $1,212 | $30 |
| Incision of pancreatic outlet using a flexible endoscope | 13 | $879 | $68 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 75 | $805 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 99 | $430 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $179 | $13 |
2016: 16 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $16,430 | $160 |
| Short return visit (20+ min) | 141 | $11,137 | $55 |
| New patient visit (45+ min) | 85 | $11,051 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $9,743 | $83 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 91 | $7,999 | $84 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 37 | $7,189 | $194 |
| Biopsy of large bowel using a flexible endoscope | 42 | $5,338 | $127 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,326 | $213 |
| New patient visit (30+ min) | 63 | $4,226 | $67 |
| Diagnostic exam of large bowel using a flexible endoscope | 27 | $3,890 | $144 |
| Return visit (30+ min) | 35 | $2,942 | $75 |
| Insertion of stomach tube using a flexible endoscope | 11 | $1,842 | $167 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,736 | $109 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,677 | $99 |
| Short return visit | 35 | $1,300 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,260 | $55 |
2015: 16 services
| Biopsy of large bowel using a flexible endoscope | 82 | $13,416 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $12,339 | $83 |
| Short return visit (20+ min) | 111 | $9,145 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 78 | $8,645 | $109 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 28 | $6,605 | $236 |
| New patient visit (30+ min) | 79 | $5,996 | $76 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $5,656 | $83 |
| Diagnostic exam of large bowel using a flexible endoscope | 33 | $5,450 | $165 |
| New patient visit (45+ min) | 40 | $5,299 | $132 |
| Return visit (30+ min) | 42 | $4,339 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,730 | $162 |
| Insertion of stomach tube using a flexible endoscope | 16 | $2,589 | $162 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,988 | $166 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,820 | $101 |
| Incision of pancreatic outlet using a flexible endoscope | 13 | $980 | $65 |
| Injection beneath lining of large bowel using a flexible endoscope | 16 | $370 | $23 |
2014: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $16,015 | $84 |
| Biopsy of large bowel using a flexible endoscope | 69 | $11,764 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 79 | $8,748 | $111 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | $8,177 | $95 |
| Short return visit (20+ min) | 107 | $7,944 | $56 |
| Return visit (30+ min) | 63 | $6,889 | $84 |
| New patient visit (45+ min) | 47 | $5,940 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,067 | $163 |
| New patient visit (30+ min) | 64 | $4,629 | $72 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 17 | $3,696 | $217 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,637 | $165 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,688 | $207 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,185 | $91 |
2013: 17 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 142 | $15,964 | $108 |
| Biopsy of large bowel using a flexible endoscope | 90 | $15,486 | $165 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 113 | $13,736 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $10,623 | $57 |
| Short return visit (20+ min) | 136 | $9,358 | $57 |
| New patient visit (45+ min) | 68 | $8,778 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $8,754 | $81 |
| Diagnostic exam of large bowel using a flexible endoscope | 50 | $8,166 | $163 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 32 | $6,988 | $206 |
| Return visit (30+ min) | 64 | $6,905 | $87 |
| New patient visit (30+ min) | 86 | $6,658 | $77 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $3,503 | $219 |
| Control of bleeding of upper large bowel using a flexible endoscope | 13 | $3,265 | $251 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,464 | $107 |
| Critical care, first 30-74 minutes | 11 | $1,914 | $174 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,906 | $159 |
| New patient visit (60+ min) | 12 | $1,878 | $156 |
Medicaid work
$132,781 in 2024
Medicaid paid $132,781 for 1,334 billed services this clinician did in 2024, up to 54 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Upper gastrointestinal endoscopy with biopsy | 211 | $35,666 |
| New patient visit (30+ min) | 334 | $27,129 |
| COLONOSCOPY W/LESION REMOVAL | 46 | $20,960 |
| Service | 113 | $14,574 |
| DIAGNOSTIC COLONOSCOPY | 29 | $12,279 |
| Short return visit (20+ min) | 211 | $7,586 |
| COLONOSCOPY AND BIOPSY | 14 | $6,770 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 68 | $3,875 |
| Return visit (30+ min) | 47 | $2,909 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 14 | $540 |
| Ringers lactate infusion, up to 1000 cc | 37 | $341 |
| Injection, diphenhydramine hcl, up to 50 mg | 15 | $86 |
| 2024 | 1,334 | 15 | 54 | $132,781 |
| 2023 | 1,042 | 16 | 28 | $87,882 |
| 2022 | 1,019 | 12 | 30 | $53,964 |
| 2021 | 726 | 10 | 41 | $42,369 |
| 2020 | 277 | 6 | 19 | $16,861 |
| 2019 | 135 | 6 | 23 | $8,265 |
| 2018 | 390 | 11 | 33 | $28,049 |
See the largest Medicaid services in earlier years
2023
| Upper gastrointestinal endoscopy with biopsy | 171 | $27,472 |
| COLONOSCOPY W/LESION REMOVAL | 43 | $14,920 |
| Service | 104 | $14,750 |
| New patient visit (30+ min) | 200 | $14,544 |
| Short return visit (20+ min) | 164 | $5,835 |
| Return visit (30+ min) | 91 | $4,372 |
| 1ST HOSP IP/OBS HIGH 75 | 39 | $2,355 |
| New patient visit (45+ min) | 22 | $1,986 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 16 | $943 |
| Service | 13 | $355 |
| Infusion, normal saline solution , 1000 cc | 29 | $278 |
| Injection, midazolam hydrochloride, per 1 mg | 31 | $20 |
2022
| Upper gastrointestinal endoscopy with biopsy | 132 | $19,224 |
| New patient visit (30+ min) | 204 | $13,939 |
| Service | 67 | $9,797 |
| Short return visit (20+ min) | 237 | $7,290 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 27 | $1,510 |
| Infusion, normal saline solution , 1000 cc | 82 | $746 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 13 | $577 |
| Return visit (30+ min) | 12 | $516 |
| Injection, midazolam hydrochloride, per 1 mg | 115 | $149 |
| Prescription drug, oral, non chemotherapeutic, nos | 14 | $92 |
| Culture, presumptive, pathogenic organisms, screening only | 14 | $82 |
| Fentanyl citrate injection | 102 | $42 |
2021
| New patient visit (30+ min) | 242 | $16,723 |
| Upper gastrointestinal endoscopy with biopsy | 56 | $10,774 |
| Short return visit (20+ min) | 232 | $6,820 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 73 | $5,430 |
| Return visit (30+ min) | 17 | $860 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $805 |
| Injection, midazolam hydrochloride, per 1 mg | 34 | $411 |
| Fentanyl citrate injection | 16 | $305 |
| Infusion, normal saline solution , 1000 cc | 32 | $241 |
| Service | 12 | $0 |
2020
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 120 | $8,926 |
| Upper gastrointestinal endoscopy with biopsy | 12 | $2,419 |
| Short return visit (20+ min) | 79 | $2,319 |
| New patient visit (30+ min) | 16 | $1,144 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 26 | $1,105 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 24 | $948 |
2019
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 48 | $3,570 |
| Upper gastrointestinal endoscopy with biopsy | 16 | $1,687 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $973 |
| New patient visit (30+ min) | 14 | $930 |
| Short return visit (20+ min) | 25 | $630 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 18 | $475 |
2018
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 135 | $10,020 |
| COLONOSCOPY AND BIOPSY | 27 | $7,908 |
| Upper gastrointestinal endoscopy with biopsy | 31 | $4,403 |
| New patient visit (45+ min) | 35 | $3,167 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $1,294 |
| Short return visit (20+ min) | 29 | $1,125 |
| Service | 28 | $81 |
| Service | 42 | $48 |
| Service | 14 | $3 |
| Service | 12 | $0 |
| Service | 14 | $0 |
Drugs they prescribed that Part D paid
$390,643
Pharmacies billed $390,643 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
579 generic and 184 brand-name prescriptions · $390,643 in drug cost · 47 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira | 15 | $102,427 | $6,828 |
| Linzess | 19 | $14,344 | $755 |
| Gavilyte-G | 196 | $3,770 | $19 |
| Sod Sulf-Potass Sulf-Mag Sulf | 52 | $3,089 | $59 |
| Cholestyramine | 11 | $2,451 | $223 |
See all 13 drugs
| Humira | 15 | $102,427 | $6,828 |
| Linzess | 19 | $14,344 | $755 |
| Gavilyte-G | 196 | $3,770 | $19 |
| Sod Sulf-Potass Sulf-Mag Sulf | 52 | $3,089 | $59 |
| Cholestyramine | 11 | $2,451 | $223 |
| Peg-3350 and Electrolytes | 100 | $1,761 | $18 |
| Gavilyte-C | 72 | $1,362 | $19 |
| Omeprazole | 83 | $1,347 | $16 |
| Dicyclomine | 32 | $349 | $11 |
| Nortriptyline | 20 | $258 | $13 |
| Clarithromycin | 11 | $251 | $23 |
| Pantoprazole | 18 | $178 | $10 |
| Amoxicillin | 15 | $117 | $8 |
Year by year
| 2024 | 763 | 490 | None | 24% | $390,643 |
| 2023 | 762 | 432 | 0% (0) | None | $594,569 |
| 2022 | 728 | 412 | 0% (0) | 31% | $282,354 |
| 2021 | 690 | 379 | 0% (0) | 53% | $337,001 |
| 2020 | 560 | 328 | None | 34% | $462,189 |
| 2019 | 643 | 379 | None | 43% | $389,558 |
| 2018 | 642 | 402 | None | None | $494,386 |
| 2017 | 584 | 356 | None | 51% | $1,009,867 |
| 2016 | 580 | 347 | None | 46% | $606,443 |
| 2015 | 428 | 257 | None | 48% | $640,572 |
| 2014 | 346 | 207 | 0% (0) | 28% | $21,897 |
| 2013 | 299 | 195 | None | 48% | $19,249 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Epclusa | 14 | $368,427 | $26,316 |
| Humira | 12 | $89,435 | $7,453 |
| Sutab | 40 | $6,811 | $170 |
| Gavilyte-G | 221 | $4,055 | $18 |
| Cholestyramine | 12 | $2,713 | $226 |
| Omeprazole | 110 | $2,381 | $22 |
| Dicyclomine | 48 | $1,200 | $25 |
| Sod Sulf-Potass Sulf-Mag Sulf | 14 | $1,078 | $77 |
| Gavilyte-C | 37 | $685 | $19 |
| Famotidine | 26 | $512 | $20 |
| Peg-3350 and Electrolytes | 26 | $450 | $17 |
| Ondansetron | 13 | $366 | $28 |
| Pantoprazole | 20 | $290 | $14 |
| Nortriptyline | 16 | $248 | $16 |
2022: 17 drugs
| Humira | 12 | $81,830 | $6,819 |
| Suprep | 97 | $10,985 | $113 |
| Mercaptopurine | 15 | $2,841 | $189 |
| Gavilyte-C | 81 | $1,614 | $20 |
| Gavilyte-G | 77 | $1,175 | $15 |
| Sod Sulf-Potass Sulf-Mag Sulf | 14 | $1,118 | $80 |
| Dicyclomine | 41 | $1,063 | $26 |
| Omeprazole | 79 | $1,029 | $13 |
| Peg-3350 and Electrolytes | 61 | $961 | $16 |
| Clarithromycin | 15 | $577 | $38 |
| Spironolactone | 14 | $408 | $29 |
| Nortriptyline | 22 | $356 | $16 |
| Famotidine | 22 | $350 | $16 |
| Lactulose | 12 | $256 | $21 |
| Prednisone | 11 | $200 | $18 |
| Amoxicillin | 17 | $131 | $8 |
| Metronidazole | 11 | $106 | $10 |
2021: 14 drugs
| Humira | 22 | $190,815 | $8,673 |
| Suprep | 272 | $29,177 | $107 |
| Zenpep | 14 | $5,435 | $388 |
| Cholestyramine | 17 | $3,723 | $219 |
| Budesonide Ec | 14 | $3,545 | $253 |
| Dicyclomine | 37 | $948 | $26 |
| Omeprazole | 71 | $776 | $11 |
| Spironolactone | 15 | $491 | $33 |
| Diphenoxylate-Atropine | 12 | $439 | $37 |
| Famotidine | 20 | $333 | $17 |
| Lactulose | 12 | $252 | $21 |
| Nortriptyline | 19 | $247 | $13 |
| Pantoprazole | 19 | $210 | $11 |
| Peg-3350 and Electrolytes | 16 | $192 | $12 |
2020: 12 drugs
| Humira | 15 | $89,189 | $5,946 |
| Suprep | 120 | $12,473 | $104 |
| Budesonide Ec | 11 | $9,512 | $865 |
| Zenpep | 11 | $2,103 | $191 |
| Gavilyte-C | 123 | $1,749 | $14 |
| Dicyclomine | 38 | $829 | $22 |
| Omeprazole | 46 | $671 | $15 |
| Nortriptyline | 20 | $223 | $11 |
| Gavilyte-G | 12 | $184 | $15 |
| Fluoxetine | 11 | $150 | $14 |
| Famotidine | 11 | $147 | $13 |
| Pantoprazole | 16 | $133 | $8 |
2019: 11 drugs
| Humira | 13 | $71,972 | $5,536 |
| Suprep | 105 | $10,335 | $98 |
| Budesonide Ec | 18 | $5,646 | $314 |
| Gavilyte-C | 98 | $1,223 | $12 |
| Omeprazole | 86 | $1,136 | $13 |
| Peg 3350-Electrolyte | 103 | $1,022 | $10 |
| Dicyclomine | 17 | $303 | $18 |
| Famotidine | 16 | $217 | $14 |
| Fluoxetine | 13 | $158 | $12 |
| Risperidone | 13 | $149 | $11 |
| Clonazepam | 11 | $25 | $2 |
2018: 14 drugs
| Humira | 12 | $59,478 | $4,956 |
| Suprep | 104 | $9,607 | $92 |
| Mercaptopurine | 14 | $2,018 | $144 |
| Peg 3350-Electrolyte | 135 | $1,370 | $10 |
| Gavilyte-C | 81 | $1,015 | $13 |
| Zolpidem Tartrate Er | 12 | $757 | $63 |
| Omeprazole | 65 | $626 | $10 |
| Clarithromycin | 12 | $539 | $45 |
| Gavilyte-G | 17 | $254 | $15 |
| Famotidine | 13 | $226 | $17 |
| Dicyclomine | 19 | $175 | $9 |
| Risperidone | 12 | $109 | $9 |
| Amoxicillin | 14 | $102 | $7 |
| Fluoxetine | 13 | $66 | $5 |
2017: 13 drugs
| Harvoni | 13 | $417,893 | $32,146 |
| Budesonide Ec | 14 | $12,448 | $889 |
| Suprep | 121 | $10,600 | $88 |
| Mercaptopurine | 14 | $1,928 | $138 |
| Peg 3350-Electrolyte | 89 | $953 | $11 |
| Gavilyte-C | 68 | $869 | $13 |
| Zolpidem Tartrate Er | 12 | $418 | $35 |
| Omeprazole | 28 | $294 | $10 |
| Gavilyte-G | 12 | $184 | $15 |
| Metronidazole | 13 | $133 | $10 |
| Risperidone | 13 | $115 | $9 |
| Dicyclomine | 14 | $97 | $7 |
| Fluoxetine | 12 | $60 | $5 |
2016: 10 drugs
| Harvoni | 15 | $484,574 | $32,305 |
| Budesonide Ec | 20 | $8,971 | $449 |
| Suprep | 82 | $6,792 | $83 |
| Dexilant | 14 | $5,774 | $412 |
| Mercaptopurine | 21 | $1,763 | $84 |
| Gavilyte-C | 88 | $1,119 | $13 |
| Peg 3350-Electrolyte | 92 | $963 | $10 |
| Omeprazole | 55 | $609 | $11 |
| Gavilyte-G | 12 | $190 | $16 |
| Metronidazole | 15 | $138 | $9 |
2015: 11 drugs
| Harvoni | 15 | $477,203 | $31,814 |
| Budesonide Ec | 11 | $8,878 | $807 |
| Suprep | 42 | $3,389 | $81 |
| Nexium | 11 | $2,696 | $245 |
| Mercaptopurine | 20 | $1,951 | $98 |
| Peg 3350-Electrolyte | 70 | $736 | $11 |
| Gavilyte-C | 51 | $601 | $12 |
| Omeprazole | 52 | $493 | $9 |
| Gavilyte-G | 32 | $457 | $14 |
| Peg-3350 and Electrolytes | 12 | $150 | $13 |
| Ciprofloxacin | 13 | $59 | $5 |
2014: 7 drugs
| Peg-3350 and Electrolytes | 96 | $1,432 | $15 |
| Mercaptopurine | 18 | $1,391 | $77 |
| Suprep | 15 | $1,171 | $78 |
| Gavilyte-G | 49 | $719 | $15 |
| Omeprazole | 43 | $514 | $12 |
| Peg 3350-Electrolyte | 17 | $192 | $11 |
| Pantoprazole | 14 | $153 | $11 |
2013: 6 drugs
| Dexilant | 15 | $2,362 | $157 |
| Peg-3350 and Electrolytes | 121 | $1,888 | $16 |
| Halflytely-Bisacodyl | 12 | $824 | $69 |
| Suprep | 11 | $720 | $65 |
| Gavilyte-G | 16 | $237 | $15 |
| Omeprazole | 20 | $193 | $10 |
Money from drug and device companies
$197 in 2025
| 2025 | 2 | 2 | None | $197 |
| 2024 | 2 | 2 | None | $75 |
| 2023 | 3 | 4 | None | $485 |
| 2022 | 2 | 9 | None | $137 |
| 2021 | 3 | 11 | None | $271 |
| 2020 | 1 | 4 | None | $93 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $105 | 1 payment
|
| Abbvie | Skyrizi | $92 | 1 payment
|
See all 2 published payments
| Madrigal Pharmaceuticals | Meals · 2025-03-12 | Rezdiffra | $105 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $92 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $75
| Boston Scientific | None | $50 | 1 payment
|
| Abbvie | Rinvoq | $24 | 1 payment
|
2023: $485
| Ovesco Endoscopy USA | None | $359 | 1 payment
|
| Boston Scientific | Exalt Model D | $87 | 1 payment
|
| AbbVie | Mavyret | $39 | 2 payments
|
2022: $137
| Abbvie | Mavyret | $121 | 8 payments
|
| Gilead Sciences | None | $16 | 1 payment
|
2021: $271
| AbbVie | Mavyret | $182 | 9 payments
|
| Nobel Biocare USA | None | $76 | 1 payment
|
| Braintree Laboratories | Sutab | $13 | 1 payment
|
2020: $93
| AbbVie | Mavyret | $93 | 4 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1538153713
- Licence
- CA C54142California C54142: Current · expires 2027-09-30
- Group
- County of San Joaquin · Permanente Medical Group Inc
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- Po Box 3346, Modesto, CA, 95353
- NPI first listed
- 2005-09-02
- NPI last updated
- 2013-02-13
This is when the NPI record was last certified, not a medical board exam.